Association of Genetic Markers in the BCL-2 Family of Apoptosis-Related Genes with Endometrial Cancer Risk in a Chinese Population

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Dorjgochoo, Tsogzolmaa ^a   Xiang, Yong Bing ^b   Long, Jirong ^a   Shi, Jiajun ^a   Deming, Sandra ^a   Xu, Wang Hong ^b,c   Cai, Hui ^a   Cheng, Jiarong ^b   Cai, Qiuyin ^a   Zheng, Wei ^a   Shu, Xiao Ou ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; GENETIC MARKER;

ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; BAD GENE; BAK1 GENE; BAX GENE; BCL 2 GENE; CANCER RISK; CARCINOGENESIS; CHINA; CHINESE; COMMUNITY; CONTROLLED STUDY; DEMOGRAPHY; ENDOMETRIUM CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; ENDOMETRIUM TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; APOPTOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84876591115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060915     Document Type: Article

References (36)

1. Antonsson B, Martinou JC, (2000) The Bcl-2 protein family. Exp Cell Res 256: 50-57.
2. Chao DT, Korsmeyer SJ, (1998) BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419.
3. Green DR, (1998) Apoptosis. Death deceiver. Nature 396: 629-630.
4. Gompel A, Sabourin JC, Martin A, Yaneva H, Audouin J, et al. (1994) Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 144: 1195-1202.
5. Otsuki Y, Misaki O, Sugimoto O, Ito Y, Tsujimoto Y, et al. (1994) Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 344: 28-29.
6. Bozdogan O, Atasoy P, Erekul S, Bozdogan N, Bayram M, (2002) Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium. Int J Gynecol Pathol 21: 375-382.
7. Bukholm IK, Nesland JM, (2000) Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 436: 224-228.
8. Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S, (2004) Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. J Am Coll Surg 198: 83-90.
9. Pappa G, Lichtenberg M, Iori R, Barillari J, Bartsch H, et al. (2006) Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from Brassicaceae. Mutat Res 599: 76-87.
10. Soda G, Antonaci A, Bosco D, Nardoni S, Melis M, (1999) Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. J Exp Clin Cancer Res 18: 363-367.
11. Kokawa K, Shikone T, Otani T, Nishiyama R, Ishii Y, et al. (2001) Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium. Hum Reprod 16: 2211-2218.
12. Mozzetti S, Ferrandina G, Marone M, D'Ingiullo F, Fruscella E, et al. (2000) Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues. Cancer Detect Prev 24: 536-541.
13. Fernandez Y, Gu B, Martinez A, Torregrosa A, Sierra A, (2002) Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state. Int J Cancer 101: 317-326.
14. Vaskivuo TE, Stenback F, Tapanainen JS, (2002) Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Cancer 95: 1463-1471.
15. Geisler JP, Geisler HE, Wiemann MC, Zhou Z, Miller GA, et al. (1998) Lack of bcl-2 persistence: an independent prognostic indicator of poor prognosis in endometrial carcinoma. Gynecol Oncol 71: 305-307.
16. Niemann TH, Trgovac TL, McGaughy VR, Vaccarello L, (1996) bcl-2 expression in endometrial hyperplasia and carcinoma. Gynecol Oncol 63: 318-322.
17. Peiro G, Diebold J, Baretton GB, Kimmig R, Lohrs U, (2001) Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Int J Gynecol Pathol 20: 359-367.
18. Porichi O, Nikolaidou ME, Apostolaki A, Tserkezoglou A, Arnogiannaki N, et al. (2009) BCL-2, BAX and P53 expression profiles in endometrial carcinoma as studied by real-time PCR and immunohistochemistry. Anticancer Res 29: 3977-3982.
19. Saegusa M, Okayasu I, (1997) Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings. J Cancer Res Clin Oncol 123: 429-434.
20. Chen K, Hu Z, Wang LE, Sturgis EM, El-Naggar AK, et al. (2007) Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 28: 2008-2012.
21. Hirata H, Hinoda Y, Kikuno N, Suehiro Y, Shahryari V, et al. (2009) Bcl2-938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy. J Urol 181: 1907-1912.
22. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, et al. (2007) Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer. Cancer Detect Prev 31: 225-232.
23. Moon JH, Sohn SK, Lee MH, Jang JH, Kim K, et al. (2010) BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients. Leuk Res 34: 166-172.
24. Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA, et al. (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87: 295-300.
25. Xu WH, Shrubsole MJ, Xiang YB, Cai Q, Zhao GM, et al. (2007) Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 16: 281-287.
26. Dorjgochoo T, Shrubsole MJ, Shu XO, Lu W, Ruan Z, et al. (2008) Vitamin supplement use and risk for breast cancer: the Shanghai Breast Cancer Study. Breast Cancer Res Treat 111: 269-278.
27. Xu HL, Xu WH, Cai Q, Feng M, Long J, et al. (2009) Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 18: 2114-2122.
28. Cai H, Xiang YB, Qu S, Long J, Cai Q, et al. (2011) Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among chinese women. Am J Epidemiol 173: 1263-1271.
29. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
30. Loerbroks A, Schouten LJ, Goldbohm RA, van den Brandt PA, (2007) Alcohol consumption, cigarette smoking, and endometrial cancer risk: results from the Netherlands Cohort Study. Cancer Causes Control 18: 551-560.
31. Parazzini F, La VC, D'Avanzo B, Moroni S, Chatenoud L, et al. (1995) Alcohol and endometrial cancer risk: findings from an Italian case-control study. Nutr Cancer 23: 55-62.
32. Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A, (2008) Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 98: 1582-1585.
33. Parazzini F, Negri E, La VC, Benzi G, Chiaffarino F, et al. (1998) Role of reproductive factors on the risk of endometrial cancer. Int J Cancer 76: 784-786.
34. Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, et al. (1996) Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 88: 1127-1135.
35. Maruo T, Laoag-Fernandez JB, Pakarinen P, Murakoshi H, Spitz IM, et al. (2001) Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium. Hum Reprod 16: 2103-2018.
36. Critchley HO, Tong S, Cameron ST, Drudy TA, Kelly RW, et al. (1996) Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo. J Reprod Fertil 115: 389-395.